Orally administered porphyrins to control intestinal iron absorption
US5223494A · kind A · utility
18Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 1990 |
| Grant date | Jun 29, 1993 |
| Priority date | — |
| Expiry date | Sep 21, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a pharmaceutical composition for oral administration to control heme oxygenase comprising mettaloprotoporhyrins and mettalomesoporphyrins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.